Table 4.

Oncological outcomes associated with various active surveillance protocols

Protocol	Patients	Mean Follow-up (years)	Treatment-Free survival	Cancer-Specific Mortality
Tosoian et al. (Johns Hopkins)(15)	769	2.7	59% at 5 years	0
Klotz et al. (University of Toronto)(16)	450	6.8	70% at 5 years	0.3% at 10 years
Bul et al. (PRIAS)(17)	2494	1.6	77% at 2 years	0
Soloway et al. (Miami)(21)	230	2.6	85.7% at 5 years	0
Dall’Era et al (18)	321	3.6	67% at 5 years	0
Selvadurai et al. (Royal Marsden)(68)	471	5.7	70% at 5 years	2% at 8 years